HIGHLIGHTS
- who: Panagiotis Bountouris and colleagues from the Ruhr University Bochum, Germany have published the paper: Benign thyroid nodules respond to a single administration of 0.3mg recombinant human thyrotropin with highly variable volume increase, in the Journal: (JOURNAL)
- what: The aim of the study was to investigate the acute effect of a low dose of rhTSH on the volume of thyroid nodules in subjects with benign non-toxic nodular thyroid disease. In these disease states, it normally takes weeks to months for the abnormal levels of thyroid hormones or TSH to alter the pituitary or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.